Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 50/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
  • Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
  • Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
  • Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
  • Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
  • Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
Find Similar Products

Basic Info.

Model NO.
TUDCA
Suitable for
Adult
State
Solid
Purity
>98%
Product Name
Tauroursodeoxycholic Acid
Mf
C26h45no6s.2H2O
CAS
14605-22-2
MOQ
1kg
Transport Package
Drum
Specification
99%
Trademark
HS
Origin
China
HS Code
2904201000
Production Capacity
100000

Product Description

Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid TudcaPharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
Product Name Tauroursodeoxycholic acid TUDCA Chemical Name
CAS NO 14605-22-2 Main Specifications ≥99.0%
Molecular Formula C26H45NO6S.2H2O Appearance White Crystalline Powder
Molecular Weight 499.70 Package Bag/Bottles/Carton
       

TUDCA is a liver aid introduced as a supplement by ThermoLife in their product Liver Longer. It looks like a good resource for preventing cholestasis.
TUDCA is an ambiphilic bile acid. It is the taurine conjugate form of ursodeoxycholic acid (UDCA). Humans are found to have trace amounts of TUDCA. However, bears contain large amounts of TUDCA in their bile.
TUDCA has diminishing apoptotic effects, helping with cardiac function, Huntington's disease, Parkinson's Disease, and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.

Taurine Ursodeoxycholic Acid (TUDCA), chemically known as 3α,7β dihydroxycholanoyl-N-taurine, is a conjugated bile acid formed by condensation between the carboxyl group of Ursodeoxycholic Acid (UDCA) and the amino group of Taurine.

Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca

Description:
Taurodeoxycholic acid is a bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues  Taurodeoxycholic acid can be found in Escherichia.
Application:
TUDCA (which has the trade name Tudcabil) is currently classified as a 'supplement' for certain liver disorders but has shown to be useful in treating amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca
Item
Specification
Appearance
White powder
Transparency
≥99.0%
pH
6.0-7.5
Glucuronic acid
≥45.0%
Protein
≤0.1%
Loss on drying
≤10.0%
Residue on ignition
15.0%-20.0%
Heavy metal
≤20ppm
As
≤2ppm
Total bacterial count
<1000cfu/g
Mold and yeast
<20cfu/g
Staphylococcus aureus
Negative
Pseudomonas aeruginosa
Negative
Pharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder TudcaPharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder TudcaPharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder TudcaPharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder TudcaPharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder TudcaPharmaceutical Intermediate CAS 14605-22-2 Tauroursodeoxycholic Acid Powder Tudca

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier